Author

A. Subbiani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Avgustinova· 1 shared A. Bachi· 1 shared A. Corrado· 1 shared A. Morandi· 1 shared A. Smiriglia· 1 shared D. L. Longo· 1 shared E. Giannoni· 1 shared F. Bonechi· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Avgustinova

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer

N. Lorito, A. Subbiani, A. Smiriglia, M. Bacci, F. Bonechi, L. Tronci, A. Corrado, D. L. Longo, M. Iozzo, L. Ippolito, G. Comito, E. Giannoni, I. Meattini, A. Avgustinova, P. Chiarugi, , A. Morandi

The paper identifies FADS1/2-mediated lipid metabolic reprogramming as a driver of ferroptosis sensitivity in triple-negative breast cancer, showing that high FADS1/2 expression correlates with poor prognosis and susceptibility to ferroptosis-inducing agents.

bioRxiv · Jun 30, 2023 · PreprintCancer Biology